AI-developed drug will be in trials by year-end, says Google’s Hassabis

Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areas

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Related Posts